Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

被引：165

作者：

French, Juliet D. ^{[1
]}

Ghoussaini, Maya ^{[2
]}

Edwards, Stacey L. ^{[1
]}

Meyer, Kerstin B. ^{[3
]}

Michailidou, Kyriaki ^{[4
]}

Ahmed, Shahana ^{[2
]}

Khan, Sofia ^{[5
,6
]}

Maranian, Mel J. ^{[2
]}

O'Reilly, Martin ^{[3
]}

Hillman, Kristine M. ^{[1
]}

Betts, Joshua A. ^{[1
]}

Carro, Thomas ^{[3
]}

Bailey, Peter J. ^{[1
]}

Dicks, Ed ^{[2
]}

Beesley, Jonathan ^{[7
]}

Tyrer, Jonathan ^{[2
]}

Maia, Ana-Teresa ^{[3
]}

Beck, Andrew ^{[8
,9
]}

Knoblauch, Nicholas W. ^{[8
,9
]}

Chen, Constance ^{[10
]}

Kraft, Peter ^{[10
,11
]}

Barnes, Daniel ^{[4
]}

Gonzalez-Neira, Anna ^{[12
]}

Rosario Alonso, M. ^{[12
]}

Herrero, Daniel ^{[12
]}

Tessier, Daniel C. ^{[13
,14
]}

Vincent, Daniel ^{[13
,14
]}

Bacot, Francois ^{[13
,14
]}

Luccarini, Craig ^{[2
]}

Baynes, Caroline ^{[2
]}

Conroy, Don ^{[2
]}

Dennis, Joe ^{[4
]}

Bolla, Manjeet K. ^{[4
]}

Wang, Qin ^{[4
]}

Hopper, John L. ^{[15
]}

Southey, Melissa C. ^{[16
]}

Schmidt, Marjanka K. ^{[17
,18
]}

Broeks, Annegien ^{[18
]}

Verhoef, Senno ^{[19
]}

Cornelissen, Sten ^{[18
]}

Muir, Kenneth ^{[20
]}

Lophatananon, Artitaya ^{[20
]}

Stewart-Brown, Sarah ^{[20
]}

Siriwanarangsan, Pomthep ^{[21
]}

Fasching, Peter A. ^{[22
,23
]}

Loehberg, Christian R. ^{[23
]}

Ekici, Arif B. ^{[24
]}

Beckmann, Matthias W. ^{[23
]}

Peto, Julian ^{[25
]}

Silva, Isabel dos Santos ^{[25
]}

机构：

[1] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia

[2] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England

[3] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 ORE, England

[4] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England

[5] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00029, Finland

[6] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland

[7] Queensland Inst Med Res, Dept Genet, Brisbane, Qld 4029, Australia

[8] Harvard Univ, Sch Med, Boston, MA 02215 USA

[9] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA

[10] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA

[11] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA

[12] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid 28029, Spain

[13] Ctr Innovat Genome Quebec, Montreal, PQ H3A 0G1, Canada

[14] McGill Univ, Montreal, PQ H3A 0G1, Canada

[15] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia

[16] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia

[17] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands

[18] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands

[19] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin, NL-1066 CX Amsterdam, Netherlands

[20] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England

[21] Minist Publ Hlth, Bangkok 10400, Thailand

[22] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA

[23] Univ Hosp Erlangen, Dept Obstet & Gynecol, Univ Breast Ctr Franconia, D-91054 Erlangen, Germany

[24] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany

[25] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1E 7HT, England

[26] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England

[27] Guys & St Thomas NHS Fdn Trust Partnership Kings, NIHR Comprehens Biomed Res Ctr, Div Canc Studies, London SE1 9RT, England

[28] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford 0X3 7BN, England

[29] Univ Oxford, Oxford Biomed Res Ctr, Oxford 0X3 7BN, England

[30] Galway Univ Hosp, Inst Clin Sci, Galway, Ireland

[31] Natl Univ Ireland, Galway, Ireland

[32] Heidelberg Univ, Dept Obstet & Gynecol, D-69115 Heidelberg, Germany

[33] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany

[34] German Canc Res Ctr, Mol Epidemiol Grp, D-69120 Heidelberg, Germany

[35] INSERM, Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, Environm Epidemiol Canc Team,U1018, F-94807 Villejuif, France

[36] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France

[37] Univ Paris Sorbonne Cite, UMR S775, INSERM, F-75270 Paris 06, France

[38] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark

[39] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark

[40] Copenhagen Univ Hosp, Dept Breast Surg, Herlev Hosp, DK-2730 Herlev, Denmark

[41] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Genet & Mol Epidemiol Grp, Madrid 28029, Spain

[42] Hosp Univ La Paz, Med Oncol Serv, Madrid 28046, Spain

[43] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo 33012, Spain

[44] Ctr Invest Red Enfermedades Raras CIBERER, Madrid 28029, Spain

[45] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA

[46] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany

[47] Saarland Canc Registry, D-66024 Saarbrucken, Germany

[48] Tech Univ Munich, Div Gynaecol & Obstet, D-81675 Munich, Germany

[49] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany

[50] Univ Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol, D-50931 Cologne, Germany

来源：

AMERICAN JOURNAL OF HUMAN GENETICS | 2013年 / 92卷 / 04期

关键词：

GENOME-WIDE ASSOCIATION; GROWTH-FACTOR RECEPTOR-2; ESTROGEN-RECEPTOR; DOWN-REGULATION; MULTIPLE LOCI; CELL-CYCLE; GATA-3; GENE; ALPHA; DIFFERENTIATION;

D O I：

10.1016/j.ajhg.2013.01.002

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Analysis of 4,405 variants in 89,050 European subjects from 41 case-control studies identified three independent association signals for estrogen-receptor-positive tumors at 11q13. The strongest signal maps to a transcriptional enhancer element in which the G allele of the best candidate causative variant rs554219 increases risk of breast cancer, reduces both binding of ELK4 transcription factor and luciferase activity in reporter assays, and may be associated with low cyclin D1 protein levels in tumors. Another candidate variant, rs78540526, lies in the same enhancer element. Risk association signal 2, rs75915166, creates a GATA3 binding site within a silencer element. Chromatin conformation studies demonstrate that these enhancer and silencer elements interact with each other and with their likely target gene, CCND1.

引用

页码：489 / 503

页数：15

共 50 条

[31] Acute myeloid leukemia (AML-M2) with t(5;11)(q35;q 13) and normal expression of cyclin D1
de Oliveira, Fabio Morato
Tone, Luiz Gonzaga
Simoes, Belinda Pinto
Falcao, Roberto Passetto
Brassesco, Maria Sol
Sakamoto-Hojo, Elza Tiemi
Silva dos Santos, Guilherme Augusto
Marinato, Andre Fiorin
Jacomo, Rafael Henriques
Rego, Eduardo Magalhaes
CANCER GENETICS AND CYTOGENETICS, 2007, 172 (02) : 154 - 157
[32] FLUORESCENT IN-SITU HYBRIDIZATION ANALYSIS OF AN ATYPICAL T(11 14)(Q13 Q32) WITHOUT EXPRESSION OF THE CYCLIN D1 GENE
RAYNAUD, SD
GRATECOS, N
SIMON, MP
CHISCHPORTICH, M
GROSGEORGE, J
GAUDRAY, P
AYRAUD, N
LEUKEMIA, 1993, 7 (11) : 1924 - 1927
[33] 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus
Mingyang Cai
Sewoon Kim
Kai Wang
Peggy J. Farnham
Gerhard A. Coetzee
Wange Lu
Scientific Reports, 6
[34] 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus
Cai, Mingyang
Kim, Sewoon
Wang, Kai
Farnham, Peggy J.
Coetzee, Gerhard A.
Lu, Wange
SCIENTIFIC REPORTS, 2016, 6
[35] FISH-mapping of chromosome 11q gains in multiple myeloma delineates a single critical region comprising chromosome bands 11q23-q25 but not the cyclin D1 gene locus at 11q13.
Liebisch, P
Wendl, C
Janczik, S
Döhner, H
BLOOD, 2003, 102 (11) : 847A - 848A
[36] LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells
Shi, Xiangmin
Wang, Xiangting
FEBS LETTERS, 2019, 593 (07) : 751 - 759
[37] Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3
Hamdi, Yosr
Soucy, Penny
Kuchenbaeker, Karoline B.
Pastinen, Tomi
Droit, Arnaud
Lemacon, Audrey
Adlard, Julian
Aittomaki, Kristiina
Andrulis, Irene L.
Arason, Adalgeir
Arnold, Norbert
Arun, Banu K.
Azzollini, Jacopo
Bane, Anita
Barjhoux, Laure
Barrowdale, Daniel
Benitez, Javier
Berthet, Pascaline
Blok, Marinus J.
Bobolis, Kristie
Bonadona, Valerie
Bonanni, Bernardo
Bradbury, Angela R.
Brewer, Carole
Buecher, Bruno
Buys, Saundra S.
Caligo, Maria A.
Chiquette, Jocelyne
Chung, Wendy K.
Claes, Kathleen B. M.
Daly, Mary B.
Damiola, Francesca
Davidson, Rosemarie
De la Hoya, Miguel
De Leeneer, Kim
Diez, Orland
Ding, Yuan Chun
Dolcetti, Riccardo
Domchek, Susan M.
Dorfling, Cecilia M.
Eccles, Diana
Eeles, Ros
Einbeigi, Zakaria
Ejlertsen, Bent
Engel, Christoph
Evans, D. Gareth
Feliubadalo, Lidia
Foretova, Lenka
Fostira, Florentia
Foulkes, William D.
BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 117 - 134
[38] Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3
Yosr Hamdi
Penny Soucy
Karoline B. Kuchenbaeker
Tomi Pastinen
Arnaud Droit
Audrey Lemaçon
Julian Adlard
Kristiina Aittomäki
Irene L. Andrulis
Adalgeir Arason
Norbert Arnold
Banu K. Arun
Jacopo Azzollini
Anita Bane
Laure Barjhoux
Daniel Barrowdale
Javier Benitez
Pascaline Berthet
Marinus J. Blok
Kristie Bobolis
Valérie Bonadona
Bernardo Bonanni
Angela R. Bradbury
Carole Brewer
Bruno Buecher
Saundra S. Buys
Maria A. Caligo
Jocelyne Chiquette
Wendy K. Chung
Kathleen B. M. Claes
Mary B. Daly
Francesca Damiola
Rosemarie Davidson
Miguel De la Hoya
Kim De Leeneer
Orland Diez
Yuan Chun Ding
Riccardo Dolcetti
Susan M. Domchek
Cecilia M. Dorfling
Diana Eccles
Ros Eeles
Zakaria Einbeigi
Bent Ejlertsen
Christoph Engel
D. Gareth Evans
Lidia Feliubadalo
Lenka Foretova
Florentia Fostira
William D. Foulkes
Breast Cancer Research and Treatment, 2017, 161 : 117 - 134
[39] Insertion of the Eu intronic enhancer at the major translocation breakpoint of mantle cell lymphoma on human chromosome 11q13 is not sufficient to activate human cyclin D1 transcription in chicken B cells.
Epner, E
Telling, A
Madisen, L
Groudine, M
BLOOD, 1998, 92 (10) : 70A - 70A
[40] Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Chenjie Zeng
Xingyi Guo
Jirong Long
Karoline B. Kuchenbaecker
Arnaud Droit
Kyriaki Michailidou
Maya Ghoussaini
Siddhartha Kar
Adam Freeman
John L. Hopper
Roger L. Milne
Manjeet K. Bolla
Qin Wang
Joe Dennis
Simona Agata
Shahana Ahmed
Kristiina Aittomäki
Irene L. Andrulis
Hoda Anton-Culver
Natalia N. Antonenkova
Adalgeir Arason
Volker Arndt
Banu K. Arun
Brita Arver
Francois Bacot
Daniel Barrowdale
Caroline Baynes
Alicia Beeghly-Fadiel
Javier Benitez
Marina Bermisheva
Carl Blomqvist
William J. Blot
Natalia V. Bogdanova
Stig E. Bojesen
Bernardo Bonanni
Anne-Lise Borresen-Dale
Judith S. Brand
Hiltrud Brauch
Paul Brennan
Hermann Brenner
Annegien Broeks
Thomas Brüning
Barbara Burwinkel
Saundra S. Buys
Qiuyin Cai
Trinidad Caldes
Ian Campbell
Jane Carpenter
Jenny Chang-Claude
Ji-Yeob Choi
Breast Cancer Research, 18

← 1 2 3 4 5 →